Chatbot could help smokers stay on track with quit meds
NCT ID NCT05997901
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a healthbot—a conversational computer program—designed to help people remember to take their varenicline (a prescription medication to help quit smoking). Researchers worked with 40 smokers in Ontario who were starting varenicline. Participants used the healthbot for 12 weeks, and the team measured how acceptable, useful, and easy to use the bot was, as well as whether it improved medication adherence and smoking cessation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
healthbot (conversational agent)
What this could lead to
If it works, this could lead to a simple, supportive tool that helps people stay on track with their smoking cessation medication, potentially improving quit rates.
What could go wrong
This is a small, early feasibility study with only 40 participants. It focuses on whether the healthbot is acceptable and usable, not on proving it helps people quit. The results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J1H4, Canada